278.59
+1.95(+0.70%)
Currency In USD
| Previous Close | 276.64 |
| Open | 278.3 |
| Day High | 281.39 |
| Day Low | 277.39 |
| 52-Week High | 293.81 |
| 52-Week Low | 199.92 |
| Volume | 590,798 |
| Average Volume | 996,867 |
| Market Cap | 40.79B |
| PE | 29.29 |
| EPS | 9.51 |
| Moving Average 50 Days | 278.14 |
| Moving Average 200 Days | 248.38 |
| Change | 1.95 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $5,929.97 as of October 04, 2025 at a share price of $278.59. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,690.17 as of October 04, 2025 at a share price of $278.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
GlobeNewswire Inc.
Sep 16, 2025 8:05 PM GMT
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Confer
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
GlobeNewswire Inc.
Sep 03, 2025 8:15 PM GMT
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health careSAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sl
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
GlobeNewswire Inc.
Aug 27, 2025 1:00 PM GMT
Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized careSAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed